Ponatinib (Ponaxen) 15mg/45mg Tablets | Bangladesh Generic | GLT

What is Ponaxen (Ponatinib)?

Ponaxen is a generic version of ponatinib, a third-generation BCR-ABL tyrosine kinase inhibitor. It is the only TKI class that maintains activity against the T315I gatekeeper mutation of BCR-ABL, which confers resistance to all first- and second-generation TKIs. Ponaxen offers the same mechanism at a more accessible price point.

What is Ponaxen Used For?

Ponaxen (ponatinib) is used for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), including cases with the T315I mutation or resistance/intolerance to prior TKI therapy.

How Does Ponatinib Work?

Ponatinib binds to the ATP-binding site of the BCR-ABL kinase domain and inhibits its activity. It was specifically designed to overcome the T315I mutation, which creates steric hindrance that blocks other TKIs from binding. By inhibiting BCR-ABL, ponatinib suppresses cancer cell proliferation and induces apoptosis.

Dosage & Administration

The recommended starting dose is 45 mg once daily, taken orally with or without food, with dose reduction to 15 mg once daily upon achievement of ≤1% BCR-ABL1 (IS) in chronic-phase CML. Dosing must be determined by the treating oncologist.

Common Side Effects

The most common adverse reactions include rash, arthralgia, abdominal pain, headache, constipation, dry skin, hypertension, fatigue, nausea, and myelosuppression (thrombocytopenia, neutropenia, anemia).

Important Safety Information

Ponatinib carries a boxed warning for arterial occlusive events, venous thromboembolic events, heart failure, and hepatotoxicity. Regular cardiovascular and liver function monitoring is required during treatment.

Storage

Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Keep in the original container and protect from light.

Why Choose the GLT?

Ponaxen offers a cost-effective alternative to the reference ponatinib product while providing the same mechanism of action. Key advantages include:

• Affordable pricing — significantly lower than reference brands
• Same BCR-ABL inhibition mechanism as reference ponatinib
• Manufactured by Everest Pharmaceuticals, an established Bangladesh manufacturer
• Global export with full documentation

Quality Assurance

All Ponaxen supplied by GIVE LIFE TIME LIMITED is sourced directly from Everest Pharmaceuticals with full batch traceability and Certificate of Analysis (COA). Every shipment includes export-ready documentation: commercial invoice, packing list, and Certificate of Origin.

How to Order

To request pricing and place an order, please follow these steps:

1. Send your prescription or case file via WhatsApp or email — reviewed within 24 hours
2. Receive a formal quotation with pricing, availability, and shipping options
3. Confirm and arrange payment via bank transfer or PayPal
4. Ship globally with full export documentation and tracking

Send your prescription / case file now: WhatsApp: +86 15234153837

Frequently Asked Questions

Is Ponaxen the same as Iclusig?

Ponaxen is a generic version of ponatinib (the active ingredient in Iclusig). It contains the same active substance and works through the same BCR-ABL inhibition mechanism, but is manufactured by Everest Pharmaceuticals rather than Takeda.

Is a prescription required?

Yes. Ponaxen is a prescription-only medicine. A valid prescription from a licensed oncologist is required.

How long does international shipping take?

Most orders are dispatched within 3-5 business days after payment confirmation, with delivery times of 7-14 business days depending on destination.

Does Ponaxen work against the T315I mutation?

Yes. Ponaxen contains ponatinib, which is the only approved TKI that maintains activity against the T315I gatekeeper mutation of BCR-ABL.